Investigation of Selected Piperazine-2,5-Diones on Their Effect on Cartilage-Related Cells †
暂无分享,去创建一个
[1] J. Fonseca,et al. Probiotic Supplementation for Rheumatoid Arthritis: A Promising Adjuvant Therapy in the Gut Microbiome Era , 2021, Frontiers in Pharmacology.
[2] Win Min Oo,et al. The Development of Disease-Modifying Therapies for Osteoarthritis (DMOADs): The Evidence to Date , 2021, Drug design, development and therapy.
[3] A. Smoliński,et al. Synthesis and Hybrid SAR Property Modeling of Novel Cholinesterase Inhibitors † , 2021, International journal of molecular sciences.
[4] J. Jampílek,et al. Chronic Inflammatory Diseases, Anti-Inflammatory Agents and Their Delivery Nanosystems , 2021, Pharmaceutics.
[5] S. Grässel,et al. Recent advances in the treatment of osteoarthritis , 2020, F1000Research.
[6] Tsutomu Takeuchi,et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update , 2020, Annals of the Rheumatic Diseases.
[7] Z. Trávníček,et al. Investigation of Anti-Inflammatory Potential of N-Arylcinnamamide Derivatives , 2019, Molecules.
[8] C. Supuran,et al. Pain Relieving Effect of-NSAIDs-CAIs Hybrid Molecules: Systemic and Intra-Articular Treatments against Rheumatoid Arthritis , 2019, International journal of molecular sciences.
[9] J. Jampílek,et al. Investigation of Permeation of Theophylline through Skin Using Selected Piperazine-2,5-Diones , 2019, Molecules.
[10] J. Jampílek,et al. Potential of Nanomaterial Applications in Dietary Supplements and Foods for Special Medical Purposes , 2019, Nanomaterials.
[11] S. Aslani,et al. Strategies toward rheumatoid arthritis therapy; the old and the new , 2018, Journal of cellular physiology.
[12] Rona R. Ramsay,et al. A perspective on multi-target drug discovery and design for complex diseases , 2018, Clinical and Translational Medicine.
[13] J. Jampílek,et al. Investigation of permeation of acyclovir through skin using alaptide , 2017 .
[14] Toru Ogata,et al. Locomotive Syndrome: Definition and Management , 2016, Clinical Reviews in Bone and Mineral Metabolism.
[15] Alan Talevi,et al. Multi-target pharmacology: possibilities and limitations of the “skeleton key approach” from a medicinal chemist perspective , 2015, Front. Pharmacol..
[16] J. Jampílek,et al. Alaptide as Transdermal Permeation Modifier , 2015 .
[17] E. Křepela,et al. Two-step generation of spirocyclic dipeptides from linear peptide ethyl ester precursors. , 1992, Life sciences.